Market Tracker

12/15 3:03am ET

ImmuCell Corp (NASDAQ:ICCC)

8.94
Delayed Data
As of Dec 14
 -0.01 / -0.11%
Today’s Change
5.00
Today|||52-Week Range
9.25
+50.25%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close8.95
Today’s open8.95
Day’s range8.80 - 8.95
Volume8,012
Average volume (3 months)11,414
Market cap$45.2M
Data as of 3:59pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio895.0
Price/Sales2.70
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc-0.01-2.61%
APVOAptevo Therapeutics ...-0.21-5.01%
BPTHBio Path Holdings In...+0.00+0.26%
CANFCan Fite Biopharma L...-0.01-0.72%
Data as of 8:00pm ET, 12/14/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts